Search research articles
Contact Us
Filters
Showing results (31-40 of 127) with videos related to
Page
of 13
Sort By:
Annals of Hematology
|
April 30, 2013
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib
Paul La Rosée, Philippe Martiat, Armin Leitner, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 18, 2020
Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer
Sheng Wu, Katja Nitschke, Thomas Stefan Worst, et al.
Anticancer Research
|
July 1, 2015
MMP9, Cyclin D1 and β-Catenin Are Useful Markers of p16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition In Vitro
Claudia Umbreit, Philipp Erben, Anne Faber, et al.
Oncotarget
|
June 15, 2018
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
Sebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, et al.
Anticancer Research
|
December 16, 2014
Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression
Claudia Umbreit, Julia Flanjak, Christel Weiss, et al.
Genes, Chromosomes & Cancer
|
November 14, 2008
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2)
Christoph Walz, Claudia Haferlach, Annette Hänel, et al.
Oncology Research and Treatment
|
October 5, 2018
Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer
Jost von Hardenberg, Thomas S Worst, Niklas Westhoff, et al.
Urologia Internationalis
|
November 14, 2017
Impact of Altered WNT2B Expression on Bladder Wall Fibroblasts: Implications for Apoptosis Regulation in the Stroma of the Lower Urinary Tract
Thomas Stefan Worst, Kristina Daskalova, Annette Steidler, et al.
Oncology Reports
|
May 12, 2012
Alteration of MMP-2 and -14 expression by imatinib in HPV-positive and -negative squamous cell carcinoma
Anne Faber, Alexander Sauter, Sarah Hoedt, et al.
Clinical Genitourinary Cancer
|
February 3, 2019
Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation
Jost von Hardenberg, Sarah Hartmann, Katja Nitschke, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 127) with videos related to
Sort By:
Page
of 13
Annals of Hematology
|
April 30, 2013
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib
Paul La Rosée, Philippe Martiat, Armin Leitner, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 18, 2020
Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer
Sheng Wu, Katja Nitschke, Thomas Stefan Worst, et al.
Anticancer Research
|
July 1, 2015
MMP9, Cyclin D1 and β-Catenin Are Useful Markers of p16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition In Vitro
Claudia Umbreit, Philipp Erben, Anne Faber, et al.
Oncotarget
|
June 15, 2018
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
Sebastien Rinaldetti, Eugen Rempel, Thomas Stefan Worst, et al.
Anticancer Research
|
December 16, 2014
Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression
Claudia Umbreit, Julia Flanjak, Christel Weiss, et al.
Genes, Chromosomes & Cancer
|
November 14, 2008
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2)
Christoph Walz, Claudia Haferlach, Annette Hänel, et al.
Oncology Research and Treatment
|
October 5, 2018
Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate Cancer
Jost von Hardenberg, Thomas S Worst, Niklas Westhoff, et al.
Urologia Internationalis
|
November 14, 2017
Impact of Altered WNT2B Expression on Bladder Wall Fibroblasts: Implications for Apoptosis Regulation in the Stroma of the Lower Urinary Tract
Thomas Stefan Worst, Kristina Daskalova, Annette Steidler, et al.
Oncology Reports
|
May 12, 2012
Alteration of MMP-2 and -14 expression by imatinib in HPV-positive and -negative squamous cell carcinoma
Anne Faber, Alexander Sauter, Sarah Hoedt, et al.
Clinical Genitourinary Cancer
|
February 3, 2019
Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation
Jost von Hardenberg, Sarah Hartmann, Katja Nitschke, et al.
Page
of 13